Cationic Liposomes Containing Mycobacterial Lipids: a New Powerful Th1 Adjuvant System

Infection and Immunity - Tập 73 Số 9 - Trang 5817-5826 - 2005
Ida Rosenkrands1, Else Marie Agger1, Anja Weinreich Olsen1, Karen Smith Korsholm1, Claire Swetman Andersen1, Klaus T. Jensen1, Peter Andersen1
1Statens Serum Institut, Department of Infectious Disease Immunology, Copenhagen, Denmark

Tóm tắt

ABSTRACT The immunostimulation provided by the mycobacterial cell wall has been exploited for many decades, e.g., in Freund's complete adjuvant. Recently, the underlying mechanism behind this adjuvant activity, including Toll receptor signaling, has begun to be unraveled, confirming the potential of mycobacterial constituents to act as adjuvants. In this study, the immunostimulatory properties of a Mycobacterium bovis BCG lipid extract were tested for their adjuvant activity. Administration of the lipids in dimethyl dioctadecyl ammonium bromide-based cationic liposomes induced a powerful Th1 response characterized by markedly elevated antigen-specific immunoglobulin G2a (IgG2a) isotype antibodies and substantial production of gamma interferon. The adjuvant formulation (designated mycosomes) elicited high levels of gamma interferon both in C57BL/6 as well as in Th2-prone BALB/c mice. Furthermore, the mycosomes induced immune responses to protein antigens from several sources including Mycobacterium tuberculosis , Chlamydia muridarum , and tetanus toxoid. In a tuberculosis challenge model, the mycosomes combined with the Ag85B-ESAT-6 fusion protein were demonstrated to have a unique ability to maintain sustained immunological memory at a level superior to live BCG.

Từ khóa


Tài liệu tham khảo

10.1128/iai.62.6.2536-2544.1994

10.1128/iai.59.6.1905-1910.1991

10.1128/iai.59.4.1558-1563.1991

10.1016/S1567-5769(01)00055-8

10.1177/09680519020080061501

10.1517/14712598.4.7.1129

10.1056/NEJM197406272902605

10.1128/IAI.72.2.937-948.2004

10.1002/elps.1150080203

10.1128/IAI.68.2.791-795.2000

10.1016/S0165-5728(99)00189-7

10.1007/BF00902745

Dobson, G., D. E. Minnikin, S. M. Minnikin, J. H. Parlett, M. Goodfellow, M. Ridell, and M. Magnusson. 1985. Systematic analysis of complex mycobacterial lipids, p. 237-265. In M. Goodfellow and D. E. Minnikin (ed.), Chemical methods in bacterial systematics, vol. 1. Academic Press, London, United Kingdom.

European Medicines Agency. 2004. Guideline on adjuvants in vaccines for human use. European Medicines Agency London United Kingdom. [Online.] http://www.emea.eu.int/pdfs/human/veg/001703en.pdf .

Freund, J. 1956. The mode of action of immunologic adjuvants, p. 130-148. In H. Birkhäuser, Advances in tuberculosis research. Karger, Basel, Switzerland.

10.1038/35047123

Higuchi, S., M. Suga, A. M. Dannenberg, Jr., L. F. Affronti, I. Azuma, T. M. Daniel, and J. P. Petrali. 1981. Persistence of protein, carbohydrate and wax components of tubercle bacilli in dermal BCG lesions. Am. Rev. Respir. Dis.123:397-401.

10.1016/0923-2494(92)80060-X

10.1128/IAI.72.3.1608-1617.2004

10.4049/jimmunol.171.3.1441

10.1038/ni1112

10.1007/978-1-4899-1382-1_16

10.1016/S0264-410X(02)00193-7

10.1016/S0264-410X(98)00084-X

10.1128/IAI.68.1.54-63.2000

10.4049/jimmunol.165.9.5177

10.1038/227680a0

10.1128/jvi.70.5.3084-3092.1996

10.1586/14760584.1.1.85

10.1016/S0264-410X(97)00268-5

10.1016/S0264-410X(01)00193-1

10.1038/nrd1176

10.1128/IAI.69.5.2773-2778.2001

10.1111/j.0105-2896.2004.00144.x

10.1084/jem.90.1.53

10.1038/nature02837

10.1128/IAI.72.9.5235-5246.2004

Suzuki, F., R. R. Brutkiewicz, and R. B. Pollard. 1986. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli. J. Natl. Cancer Inst.77:441-447.

10.1016/j.vaccine.2003.09.017

10.1128/cdli.2.1.30-34.1995

Veronesi, R., A. Correa, and D. Alterio. 1970. Single dose immunization against tetanus. Promising results in human trials. Rev. Inst. Med. Trop. Sao Paulo12:46-54.

10.1006/mthe.2002.0545

10.1007/s00232-002-1015-7